• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Remedy Robotics Raises $62M to Advance Remote Endovascular Stroke Robotics Toward FDA Approval

by Fred Pennic 11/16/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Remedy Robotics Raises $62M to Advance Remote Endovascular Stroke Robotics Toward FDA Approval

What You Should Know

  • San Francisco-based healthcare and physical AI company Remedy Robotics raises $62M in Series B funding led by returning investor DCVC to advance its AI-enabled endovascular robotic platform, the N1 System, toward pivotal clinical trials and FDA approval.
  • New institutional investors joining the Series B syndicate include UC Investments (the University of California’s investment office), Skip Capital, and Australian pension fund Hostplus, alongside returning backers Build Collective by Tony Fadell, Blackbird, Divergent Capital, and KdT Ventures.
  • Proceeds will fund a planned pivotal neurovascular clinical trial in partnership with the University of California network, expand prototype N1 System deployments across strategic clinical alliances—including SVIN Mission Thrombectomy and the Australian Stroke Alliance—and accelerate autonomous robotic software development.
  • Engineered for on-site, remote, or autonomous operation across neurovascular, coronary, and peripheral vascular interventions, the N1 System utilizes machine learning to analyze preoperative imaging, simulate procedures in advance, and execute real-time 3D-2D image registration.

The N1 Platform: Physical AI, Preoperative Simulation, and Remote Endovascular Execution

Backed by 48 issued patents spanning machine learning and surgical robotics, Remedy Robotics engineered the N1 System to decouple specialist expertise from physical bedside presence. The platform integrates precision catheter-driving hardware with an artificial intelligence software suite capable of supporting on-site, tele-operated remote, and progressively autonomous endovascular procedures across neurovascular, coronary, and peripheral vascular indications.

Prior to vascular access, the N1 software analyzes preoperative computed tomography and angiographic imaging to simulate patient-specific vascular anatomy and tortuosity in advance. During live procedures, the system executes real-time 3D-to-2D image registration—overlaying three-dimensional preoperative vascular maps onto two-dimensional intraoperative fluoroscopy—enabling interventionalists operating from remote hubs to navigate microcatheters and stent retrievers through delicate cerebral arteries with sub-millimeter precision. Currently collaborating with more than 100 hospitals worldwide, Remedy is scaling prototype deployments through global clinical partnerships including SVIN Mission Thrombectomy and the Australian Stroke Alliance, while advancing software capabilities toward full procedural autonomy.

“Endovascular intervention is the gold standard treatment for stroke and many cardiovascular emergencies, yet access remains limited to a small number of hospitals. For these time-critical conditions, that’s devastating. Even when specialist intervention is available, treatment is often delayed, and complications are frustratingly common,” said Dr. David Bell, CEO and Co-founder of Remedy Robotics. “This funding will allow us to accelerate toward deployment of our N1 System so we can bring quality intervention to patients everywhere, regardless of geography.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |